As of November 6, 2026, Select Medical Holdings Corp has reported one leadership change filing to the SEC under Item 5.02 of Form 8-K, on July 1, 2026 (Form 8-K, July 1, 2026).
30 companies changed executives this week.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| John Hancock Comvest Private Income Fund | named a new Chief Financial Officer | |
| Bain Capital Specialty Finance, Inc. | named a new Director | |
| Azora Therapeutics, Inc. (DE) | named a new Director | |
| LASE Corp. | named a new Director | |
| Century Communities, Inc. | named a new Executive Chairman |
Sell to companies like Select Medical Holdings Corp? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Select Medical Holdings Corp reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-07-01. Every row below is cited to the filing it comes from, and this page adds each new change as Select Medical Holdings Corp files it.
Also on the record for Select Medical Holdings Corp
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| August 13, 2026 | Stake report, Schedule 13G/A, by Glazer Capital, LLC | 8.67% of the class | 5%+ stakes | Source |
| July 31, 2026 | Stake report, Schedule 13G/A, by Vanguard Portfolio Management | — | 5%+ stakes | Source |
| July 30, 2026 | Stake report, Schedule 13G/A, by BlackRock, Inc. | 9.9% of the class | 5%+ stakes | Source |
| July 1, 2026 | Stake report, Schedule 13D/A, by ORTENZIO ROBERT A | — | 5%+ stakes | Source |
| May 14, 2026 | Stake report, Schedule 13G, by Glazer Capital, LLC | 5.21% of the class | 5%+ stakes | Source |
| April 29, 2026 | Stake report, Schedule 13G, by Vanguard Portfolio Management | 5.45% of the class | 5%+ stakes | Source |
| April 8, 2026 | Stake report, Schedule 13G/A, by T. Rowe Price Associates, Inc. | 0.1% of the class | 5%+ stakes | Source |
| March 27, 2026 | Stake report, Schedule 13G/A, by The Vanguard Group | — | 5%+ stakes | Source |
| March 4, 2026 | Stake report, Schedule 13D/A, by ORTENZIO ROBERT A | 11.3% of the class | 5%+ stakes | Source |
| February 23, 2026 | Stake report, Schedule 13D/A, by ORTENZIO ROBERT A | 11.3% of the class | 5%+ stakes | Source |
| November 24, 2025 | Stake report, Schedule 13D, by ORTENZIO ROBERT A | 11.3% of the class | 5%+ stakes | Source |
Selling to them or working with them? See who runs Select Medical Holdings Corp now and the warning signs.
Free to see. No signup.
Keep reading
More on Select Medical Holdings Corp and the records around it.
Select Medical Holdings Corp elsewhere on the record
- 5%+ stake filings Aug 2026
Companies that share a holder
- ORTENZIO ROBERT A also filed stake reports on 1 other company: Concentra Group Holdings Parent, Inc. (Sep 2026)
- Glazer Capital, LLC also filed stake reports on 107 other companies: Bumble Inc (Oct 2026), Weave Communications Inc (Oct 2026), Utz Brands Inc (Oct 2026)
- T. Rowe Price Associates, Inc. also filed stake reports on 191 other companies: PACIFIC BIOSCIENCES OF CALIF (Nov 2026), APARTMENT INVT & MGMT CO -A (Oct 2026), BETA BIONICS INC (Oct 2026)
Watch Select Medical Holdings Corp
Get an email when Select Medical Holdings Corp files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Select Medical Holdings Corp?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Select Medical Holdings Corp: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Select Medical Holdings Corp covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
12 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-07-01 | Reported | not named in the filing | 8-K, 2026-07-01 |
New leaders reset buying decisions — get the Full Report on Select Medical Holdings Corp: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the senior executive at Select Medical Holdings Corp, with the record behind each one.
Find candidates like senior executive at Select Medical Holdings CorpEvery change, in the filing's words
Reported
These departures were in connection with the closing of the Merger and not due to any disagreement with the Company on any matter.
- In connection with the completion of the Merger, at the Effective Time, each of William H. Frist, Daniel J. Thomas, Katherine R. Davisson, Parvinderjit S. Khanuja, James S. Ely III, Thomas A. Scully and Marilyn B. Tavenner ceased to be directors of the Company.
- In connection with the Merger, Russell L. Carson, David S. Chernow and Robert A. Ortenzio serve as the directors of the Company, as of the Effective Time.
Tools for this story
Each opens in a new tab, filled in for Select Medical Holdings Corp. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.